NEW YORK, NY--(Marketwired - Jan 2, 2015) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased shares of Roka Bioscience, Inc. ("Roka" or the "Company") (NASDAQ: ROKA) securities between July 17, 2014 and November 6, 2014.

For more information, click here:

The complaint alleges that Roka's initial public offering documents failed to disclose known trends and uncertainties about the decline in demand for its Atlas instruments.

On November 6, 2014, Roka announced a net loss of $0.64 per share in the third quarter of 2014. The Company also acknowledged it had not placed any Atlas instruments in that quarter.

If you suffered a loss in Roka you have until February 23, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510